HELX vs. FBT
HELX (Franklin Genomic Advancements ETF) and FBT (First Trust Amex Biotechnology Index) are both Health & Biotech Equities funds. HELX is actively managed, while FBT is passively managed. Over the past 5 years, HELX returned -4.32%/yr vs 6.79%/yr for FBT. Their correlation of 0.82 suggests significant overlap in exposure. HELX charges 0.50%/yr vs 0.57%/yr for FBT.
Performance
HELX vs. FBT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HELX achieves a -5.49% return, which is significantly lower than FBT's 7.08% return.
HELX
- 1D
- -2.11%
- 1M
- 2.72%
- YTD
- -5.49%
- 6M
- -7.61%
- 1Y
- 31.41%
- 3Y*
- 4.34%
- 5Y*
- -4.32%
- 10Y*
- —
FBT
- 1D
- 2.92%
- 1M
- 6.19%
- YTD
- 7.08%
- 6M
- 3.95%
- 1Y
- 35.94%
- 3Y*
- 12.40%
- 5Y*
- 6.79%
- 10Y*
- 8.86%
HELX vs. FBT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
HELX Franklin Genomic Advancements ETF | -5.49% | 26.34% | -5.32% | 1.14% | -37.89% | 9.80% | 85.05% |
FBT First Trust Amex Biotechnology Index | 7.08% | 24.25% | 5.88% | 2.55% | -4.83% | -2.26% | 18.81% |
Correlation
The correlation between HELX and FBT is 0.86, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.86 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.86 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.85 |
Correlation (All Time) Calculated using the full available price history since Feb 28, 2020 | 0.82 |
The correlation between HELX and FBT has been stable across timeframes, ranging from 0.82 to 0.86 - a consistent structural relationship.
HELX vs. FBT - Sectors Allocation Comparison
Sectors
HELX
FBT
Healthcare
Basic Materials
-
Technology
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Utilities
-
-
Healthcare
HELX
FBT
Basic Materials
HELX
FBT
-
Technology
HELX
FBT
-
Communication Services
HELX
-
FBT
-
Consumer Cyclical
HELX
-
FBT
-
Consumer Defensive
HELX
-
FBT
-
Energy
HELX
-
FBT
-
Financial Services
HELX
-
FBT
-
Industrials
HELX
-
FBT
-
Real Estate
HELX
-
FBT
-
Utilities
HELX
-
FBT
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HELX vs. FBT — Risk / Return Rank
HELX
FBT
HELX vs. FBT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Franklin Genomic Advancements ETF (HELX) and First Trust Amex Biotechnology Index (FBT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HELX | FBT | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.51 | 1.74 | -0.22 |
Sortino ratioReturn per unit of downside risk | 2.18 | 2.56 | -0.37 |
Omega ratioGain probability vs. loss probability | 1.26 | 1.31 | -0.05 |
Calmar ratioReturn relative to maximum drawdown | 1.83 | 2.53 | -0.70 |
Martin ratioReturn relative to average drawdown | 4.78 | 7.43 | -2.65 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HELX | FBT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.51 | 1.74 | -0.22 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.18 | 0.31 | -0.49 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.37 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.22 | 0.51 | -0.29 |
Drawdowns
HELX vs. FBT - Drawdown Comparison
The maximum HELX drawdown since its inception was -58.75%, which is greater than FBT's maximum drawdown of -40.51%. Use the drawdown chart below to compare losses from any high point for HELX and FBT.
Loading charts...
Drawdown Indicators
| HELX | FBT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.75% | -40.51% | -18.24% |
Max Drawdown (1Y)Largest decline over 1 year | -18.01% | -14.26% | -3.75% |
Max Drawdown (3Y)Largest decline over 3 years | -29.48% | -20.05% | -9.43% |
Max Drawdown (5Y)Largest decline over 5 years | -58.75% | -29.05% | -29.70% |
Max Drawdown (10Y)Largest decline over 10 years | — | -32.37% | — |
Current DrawdownCurrent decline from peak | -40.70% | -0.72% | -39.98% |
Average DrawdownAverage peak-to-trough decline | -34.31% | -11.17% | -23.14% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.91% | 4.85% | +2.06% |
Volatility
HELX vs. FBT - Volatility Comparison
Franklin Genomic Advancements ETF (HELX) and First Trust Amex Biotechnology Index (FBT) have volatilities of 7.00% and 6.94%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HELX | FBT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.00% | 6.94% | +0.06% |
Volatility (6M)Calculated over the trailing 6-month period | 16.24% | 15.87% | +0.37% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.89% | 20.79% | +0.10% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.13% | 21.89% | +2.24% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.40% | 23.91% | +3.49% |
HELX vs. FBT - Expense Ratio Comparison
HELX has a 0.50% expense ratio, which is lower than FBT's 0.57% expense ratio.
Dividends
HELX vs. FBT - Dividend Comparison
HELX's dividend yield for the trailing twelve months is around 0.42%, while FBT has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBT First Trust Amex Biotechnology Index | 0.00% | 0.00% | 0.71% | 0.00% | 0.00% | 1.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.12% |
HELX Franklin Genomic Advancements ETF | 0.42% | 0.39% | 0.00% | 0.00% | 0.00% | 0.24% | 0.12% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
HELX and FBT have a correlation of 0.86, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HELX has higher volatility (7.00%) compared to FBT (6.94%). In terms of maximum drawdown, HELX dropped -58.75% vs FBT's -40.51%.
On 5-year performance, FBT leads with 6.79% vs -4.32% for HELX. On fees, HELX is cheaper at 0.50% per year. Their volatility is very similar. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, FBT has performed better with a 6.79% return vs -4.32%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
HELX is cheaper with a 0.50% expense ratio, compared with 0.57% for FBT.
HELX has the higher dividend yield at 0.42%, compared with 0.00% for FBT.
They also come from different issuers: Franklin Templeton and First Trust. Their fees differ too: 0.50% for HELX and 0.57% for FBT.
FBT currently has the higher Sharpe Ratio (1.74 vs 1.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HELX and FBT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer